Institute of Molecular Genetics of the Czech Academy of Sciences
| Grant name | Provider | Duration | Investigator | Web |
|---|---|---|---|---|
| Decoding unique metabolic dispositions of malignant clones responsible for adverse prognosis in acute lymphoblastic leukemia: cancer metabolism as a new therapeutic target in leukemias | Ministry of Health | 2022-2025 | M. Alberich Jordà | Go to website |
| Exploring emergency granulopoiesis under sterile chronic inflammation | Czech Science Foundation | 2024-2026 | M. Alberich Jordà | Go to website |
| Dissecting the role of bone marrow microenvironment behind chemoresistance development in acute lymphoblastic leukemia | Ministry of Health | 2024-2027 | M. Alberich Jorda | Go to website |
| Deciphering transcriptional regulation and metabolic adaptations during emergency granulopoiesis in hematopoietic stem cells | Czech Science Foundation | 2025-2027 | M. Alberich Jorda |
| Grant name | Provider | Duration | Investigator | Web |
|---|---|---|---|---|
| C/EBPgamma in normal hematopoiesis and acute myeloid leukemia: identification of molecular mechanisms involved in cell transformation | Ministry of Education, Youth and Sports | 2013-2015 | M. Alberich-Jorda | Go to website |
| Function of the transmembrane protein Evi2b in hematopoiesis | Czech Science Foundation | 2015-2017 | M. Alberich Jorda | Go to website |
| Mechanisms regulating normal and leukemic hematopoietic stem cells: Deciphering the role of the beta-catenin/Tcf signaling pathway | Czech Science Foundation | 2017-2019 | M. Alberich Jorda | Go to website |
| The transcription factor C/EBPg as a novel regulator in mast cell development and function | Czech Science Foundation | 2018-2020 | M. Alberich Jorda | Go to website |
| Role of leukemia cell metabolism in disease manifestation, progression and therapy response | Ministry of Health | 2018-2021 | M. Alberich Jorda | Go to website |
| Effects of chronic inflammation on hematopoietic stem cells and leukemia development | Czech Science Foundation | 2020-2022 | M. Alberich Jorda | Go to website |
| Molecular basis of human enhanceropathies | EU Framework Programme for Research and Innovation | 2020-2024 | M. Alberich Jorda | Go to website |
| Evaluation of ALDH1A inhibitors as a potential drugs in the treatment of acute myeloid leukemia by using patient-derived xenografts | Czech Academy of Sciences | 2021-2023 | MK. Adamcová | |
| Emergency granulopoiesis at the level of hematopoietic stem and progenitor cells: The role of population dynamics and Wnt/-catenin signaling | Czech Science Foundation | 2022-2024 | M. Alberich Jordà | Go to website |
